研究单位：[1]Jiangsu HengRui Medicine Co., Ltd.[2]Tongji Hospital Affiliated to Tongji University Shanghai, Shanghai, China, 200065[3]West China Hospital Chendu, Sichuan, China, 610041[4]Tianjin Medical University General Hospital Tianjin, Tianjin, China, 300052[5]Ningbo No.2 Hospital Ningbo, Zhejiang, China, 315010[6]The First Hospital of Jilin University Changchun, Jilin, China, 130021[7]Affiliated Hospital,Jiangnan University Wuxi, Jiangsu, China, 214062[8]the Third Xiangya Hospital of Central South University Changsha, Hunan, China, 410013[9]No.1 People's Hospital of Chenzhou City Chenzhou, Hunan, China, 423000[10]The Third Hospital of Hebei Medical University Shijiazhuang, Hebei, China, 050051[11]Guizhou Provincial People's Hospital Guiyang, Guizhou, China, 551100[12]Liuzhou General Hospital Liuzhou, Guangxi, China, 545006[13]Fuzhou General Hospital of Nanjing Millitary Command Fuzhou, Fujian, China, 350025[14]The South West Hospital Chongqing, Chongqing, China, 400042[15]Beijing Hospital Beijing, Beijing, China, 100730[16]Beijing Friendship Hospital Beijing, Beijing, China, 100050[17]Beijing Chao-Yang Hospital Beijing, Beijing, China, 100020
Paracetamol,a classical analgesic agent,constitutes an essential component of multi-modal analgesia. This medication is generally safe, well tolerated and effective within recommended daily dose.The purpose of the study is to evaluate the efficacy and safety of Paracetamol Injection as adjuvant to morphine-based post-operative analgesia, as well as to explore the reasonable dosage of paracetamol among Chinese population under above-mentioned circumstance.
